,i #aai? ,,congress #a/ ,session ,h4 ,r4 #bdga ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #bg1 #bjbe,mr4 ,swalwell 7= himself & ,mr4 ,cr5%aw7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to update ! ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion to consid] advances 9 ph>macog5omic rese>* & te/+1 to improve electronic heal? records = ph>macog5omic in=mation1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,"r ,drug ,dose ,n[ ,act ( #bjbe4 #b4 ,table ( cont5ts ,! table ( cont5ts ( ?is ,act is z foll[s3 ,sec4 #a4 ,%ort title4 ,sec4 #b4 ,table ( cont5ts4 ,sec4 #c4 ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion4 ,sec4 #d4 ,adv]se drug ev5t & ph>macog5omic te/+ education = heal? c>e pr(essionals4 ,sec4 #e4 ,improv+ ,,ehr sy/ems to improve ! use ( ph>macog5omic in=mation4 #c4 ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion ,! ,secret>y ( ,heal? & ,human ,s]vices 79 ?is ,act ref]r$ to z ! ,secret>y7 %all-- 7#a7 n lat] ?an #ahj days aft] ! date ( enactm5t ( ?is ,act1 9 coord9ation ) ! heads ( o!r relevant ,f$]al dep>tm5ts & ag5cies1 submit a report to ! ,congress on ! implem5tation ( ! ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion ( ! ,dep>tm5t ( ,heal? & ,human ,s]vices1 includ+ on ! progress 9 meet+ ! t>get outcomes approv$ by ! ,f$]al ,int]ag5cy ,/e]+ ,committee = ,adv]se ,drug ,ev5ts2 7#b7 conv5e ! ,f$]al ,int]ag5cy ,/e]+ ,committee = ,adv]se ,drug ,ev5ts to update ! ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion2 & 7#c7 require su* ,committee1 9 updat+ ! ,national ,action ,plan = ,adv]se ,drug ,ev5t ,prev5tion-- 7,a7 to consid] advances 9 sci5tific und]/&+ & te*nology p]ta9+ to drug-g5e int]actions 7includ+ int]actions among multiple drugs & g5es71 cl9ical outcomes1 heal? c>e utilization1 & ! decreas+ co/ ( g5etic te/+2 7,b7 to assess ! role ( ph>macog5etics te/+ comb9$ ) cl9ical decision support z an evid5ce-bas$ prev5tion tool2 & 7,c7 to evaluate op]at+ *>act]i/ics = ,f$]al adv]se drug ev5t monitor+ sy/ems & exp& capabilities to id5tify g5etic associations 9 adv]se ev5ts4 #d4 ,adv]se drug ev5t & ph>macog5omic te/+ education = heal? c>e pr(essionals ,! ,secret>y %all issue guidance = heal? c>e provid]s & heal? c>e lead]s1 includ+ adm9i/rators1 prim>y & specialty c>e physicians1 ph>maci/s1 nurse practition]s1 physician assi/ants1 physician m$ical g5etici/s1 laboratory m$ical g5etici/s1 g5etic c\nselors1 m$ical educators1 & ! faculty ( s*ools ( m$ic9e & o!r s*ools ( heal? pr(essions1 on ! foll[+3 7#a7 ,ph>macog5omic te/+ & ! ext5t ( its ability to prev5t adv]se drug reactions4 7#b7 ,ph>macog5omic te/+1 drug int]action al]t+ sy/ems1 :5 to ref] to or consult ) a g5etics provid]1 & ! applicable ,f$]al /&>ds ( c>e = pati5ts :o are suspect$ or kn[n to h a g5etic v>iant t is kn[n to impact drug metabolism or adv]se reactions4 7#c7 ,evid5ce-bas$ in=mation t w\ld enc\rage individuals & _! heal? c>e pr(essionals to consid] ph>macog5omic te/+ z "p ( _! heal? c>e plan to ! ext5t appropriate4 7#d7 ,! role ( m$ical pr(essionals :o specialize 9 g5etics & g5omics4 7#e7 ,h[ to incorporate ph>macog5omics into compreh5sive m$ication managem5t4 7#f7 ,! importance ( report+ in=mation ab\t kn[n & relevant ph>macog5omic in=mation :5 report+ adv]se drug ev5ts to ! ,,fda ,adv]se ,ev5t ,report+ ,sy/em4 #e4 ,improv+ ,,ehr sy/ems to improve ! use ( ph>macog5omic in=mation 7a7 ,c]tification crit]ia ,! ,secret>y %all provide guidance = heal? c>e provid]s & heal? c>e lead]s1 includ+ adm9i/rators1 prim>y & specialty c>e physicians1 ph>maci/s1 nurse practition]s1 physician assi/ants1 physician m$ical g5etici/s1 laboratory m$ical g5etici/s1 g5etic c\nselors1 m$ical educators1 & ! faculty ( s*ools ( m$ic9e & o!r s*ools ( heal? pr(essions1 on heal? in=mation te*nologies1 includ+ = electronic prescrib+ sy/ems & real-"t ph>macy b5efit *ecks1 reg>d+ h[1 be=e a m$ication ord] is complet$ & act$ ^u dur+ comput]iz$ provid] ord] entry1 int]v5tions might automatically indicate to a us]-- 7#a7 :5 ph>macog5omic te/+ is appropriate bas$ on a drug product's label or pe]-review$ pr(essional guidel9es2 & 7#b7 drug-g5e & drug-drug-g5e associations1 e/abli%$ by a drug product's label or pe]-review$ pr(essional guidel9es1 bas$ on a pati5t's m$ication li/1 m$ication all]gy li/1 & results f ph>macog5omic te/+4 7b7 ,guidance on drug-,g5e int]action al]t+ sy/ems 7#a7 ,issuance & updates ,! ,secret>y %all-- 7,a7 issue r\t9e guidance on drug-g5e int]action al]t+ sy/ems 9 electronic heal? records2 & 7,b7 n less ?an biannually1 update su* guidance to incorporate ph>macog5omic in=mation f-- 7i7 new or updat$ drug labels2 & 7ii7 newly e/abli%$ pe]-review$ pr(essional guidel9es on drug-g5e associations4 7#b7 ,rule ( con/ruction ,no?+ 9 p>agraph 7#a7 %all be con/ru$ z prohibit+ an entity f updat+ ! results ( ph>macog5omic te/+1 or al]t+ ! provid]1 if a m$ication is contra9dicat$ by ! results ( ph>macog5omic te/+4 7c7 ,r$uc+ adv]se drug ev5ts report+ burd5s ,! ,secret>y %all enc\rage ! developm5t ( electronic heal? record sy/ems t all[ = adv]se drug ev5t in=mation to be directly report$ to ! ,,fda ,adv]se ,ev5t ,report+ ,sy/em4 7d7 ,updat+ ,,fa]s2 pati5t-,fri5dly report+ ,! ,secret>y %all-- 7#a7 update ! ,,fda ,adv]se ,ev5t ,report+ ,sy/em1 includ+ to-- 7,a7 create an optional selection tool t all[s individuals to report :e!r an adv]se drug ev5t is associat$ ) a drug-g5e or drug-drug-g5e int]action2 & 7,b7 accept in=mation directly f heal? c>e provid]s' electronic heal? record sy/ems2 7#b7 "w ) relevant ,f$]al ag5cies & (fices1 & /akehold]s1 to create pati5t-fri5dly electronic options = report+ adv]se drug ev5ts su* z submission ?r\gh an optional designat$ mobile device application or mobile device messag+ application2 & 7#c7 n lat] ?an #a ye> aft] ! date ( enactm5t ( ?is ,act1 report to ! ,congress on ! progress made 9 implem5t+ p>agraphs 7#a7 & 7#b74 7e7 ,,gao /udy & recomm5dations on inclusion ( in=mation on drug-,g5e int]actions on drug labels ,n lat] ?an #ahj days aft] ! date ( enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all-- 7#a7 /udy1 & =mulate recomm5dations on1 h[ ! ,food & ,drug ,adm9i/ration c include & update in=mation on drug-g5e int]actions on drug labels2 & 7#b7 submit recomm5dations to ! relevant committees ( jurisdiction4 7f7 ,report on additional improvem5ts to electronic heal? record sy/ems 7#a7 ,9 g5]al ,n lat] ?an #ahj days aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y %all-- 7,a7 complete a report on additional improvem5ts to electronic heal? record sy/ems t are ne$$ to fur!r ! developm5t ( real _w evid5ce 7z def9$ 9 section #eje;,f ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;g77 9 ph>macog5omics2 & 7,b7 submit su* report to ! ,congress4 7#b7 ,consid]ation ( ne$$ advancem5ts ,z "p ( ! report "u p>agraph 7#a71 ! ,secret>y %all consid] :at advancem5ts are ne$$ 9 electronic heal? record sy/ems to capture in=mation ab\t ! laboratory & ! te/ us$ z "p ( ph>macog5omic te/+4